search
Back to results

'Low-salt' Bread as a Means of Reducing Dietary Salt and Lowering Blood Pressure (Saltbreads)

Primary Purpose

Elevated Blood Pressure

Status
Completed
Phase
Not Applicable
Locations
Ireland
Study Type
Interventional
Intervention
Usual-salt diet
Reduced-salt diet
Sponsored by
University College Cork
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Elevated Blood Pressure focused on measuring Low-salt bread, Dietary sodium restriction, Pre-hypertension, Hypertension stage 1

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • consenting adult Caucasian men and women, aged ≤65 y;
  • a seated office systolic BP >120 and <160 mmHg and/or a diastolic BP >80 and <95 mmHg (based on the mean BP across 3 screening visits as part of a pre-intervention phase of the trial)
  • willing to consume study breads

Exclusion Criteria:

  • taking anti-hypertensive medication;
  • taking any medications known to interfere with blood pressure or calcium or bone metabolism;
  • Severe medical illness;
  • celiac disease;
  • hypercalcemia;
  • known intestinal malabsorption syndrome,
  • excessive alcohol use (>14 drinks/week);
  • pregnancy

Sites / Locations

  • School of Food and Nutritional Sciences, University College Cork

Arms of the Study

Arm 1

Arm 2

Arm Type

Placebo Comparator

Active Comparator

Arm Label

Usual-salt diet

Reduced-salt diet

Arm Description

Usual-salt diet followed for 5 weeks

Reduced-salt diet followed for 5 weeks

Outcomes

Primary Outcome Measures

Systolic blood pressure at end of intervention periods
Measured as seated office systolic blood pressure at end of usual salt dietary period and at end of reduced-salt dietary period

Secondary Outcome Measures

Diastolic blood pressure
Measured as seated office diastolic blood pressure at end of usual salt dietary period and at end of reduced-salt dietary period
Urinary Calcium
Assessed in 24-hour urine collected at end of usual salt dietary period and at end of reduced-salt dietary period
Urinary N-telopeptides of Type I collagen
Biomarker of bone resorption; Assessed in 24-hour urine collected at end of usual salt dietary period and at end of reduced-salt dietary period
Serum Parathyroid Hormone
Index of calcium metabolism; Assessed in 24-hour urine collected at end of usual salt dietary period and at end of reduced-salt dietary period
Serum C-telopeptide of Type I collagen
Biomarker of bone resorption; Assessed in 24-hour urine collected at end of usual salt dietary period and at end of reduced-salt dietary period
Serum Osteocalcin
Biomarker of bone formation; Assessed in fasting serum collected at end of usual salt dietary period and at end of reduced-salt dietary period
Serum Bone-specific alkaline phosphatase
Biomarker of bone formation; Assessed in fasting serum collected at end of usual salt dietary period and at end of reduced-salt dietary period
Plasma triglycerides
Index of circulating lipids and CHD risk; Assessed in fasting plasma collected at end of usual salt dietary period and at end of reduced-salt dietary period
Serum total-cholesterol
Index of circulating lipids and CHD risk; Assessed in fasting plasma collected at end of usual salt dietary period and at end of reduced-salt dietary period
Plasma LDL-cholesterol,
Index of circulating lipids and CHD risk; Assessed in fasting plasma collected at end of usual salt dietary period and at end of reduced-salt dietary period
Plasma HDL-cholesterol
Index of circulating lipids and CHD risk; Assessed in fasting plasma collected at end of usual salt dietary period and at end of reduced-salt dietary period

Full Information

First Posted
June 21, 2019
Last Updated
June 28, 2019
Sponsor
University College Cork
search

1. Study Identification

Unique Protocol Identification Number
NCT04003597
Brief Title
'Low-salt' Bread as a Means of Reducing Dietary Salt and Lowering Blood Pressure
Acronym
Saltbreads
Official Title
'Low-salt' Bread as Part of a Pragmatic Reduced-salt Diet for Lowering Blood Pressure in Adults With Elevated Blood Pressure
Study Type
Interventional

2. Study Status

Record Verification Date
June 2019
Overall Recruitment Status
Completed
Study Start Date
January 3, 2008 (Actual)
Primary Completion Date
July 30, 2010 (Actual)
Study Completion Date
July 30, 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University College Cork

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
In the context of public health, reformulation of bread in terms of salt content remains an important measure to help achieve a reduction in salt intake in the population. Therefore, the aim of this study was to examine, using a 5-week cross-over design, food-based intervention trial, the potential for inclusion of 'low-salt' bread as part of a pragmatic reduced-salt diet on blood pressure (BP) in adults with slightly to moderately elevated BP. The study consisted of a randomized crossover trial of the effect of reduced-salt intake or usual-salt intake for 5 weeks on BP (as the primary outcome) in adults with slightly to moderately elevated BP (seated office systolic BP >120 and <160 mmHg or a diastolic BP >80 and <95 mmHg; identified by a pre-screening phase). Subjects were randomly assigned to the reduced-salt diet or their usual-salt diet (control) for 5 weeks, followed by crossover to the alternative dietary regimen for a further 5 weeks. Subjects randomized to start on the reduced-salt diet were asked to restrict their consumption of dietary salt using a combination of pragmatic dietary advice as well as the replacement of bread and a limited number of other foods with equivalent foods which had lower salt content; these were provided to the participants. At the beginning of the salt restriction period, a research nutritionist provided the subjects with a list of the common salt-containing food and were asked to limit the consumption of such, as feasible. The subjects received in-house prepared 'low-salt (<0.3 g/100 g)' brown or white sliced pan bread as well as no-salt margarine/butter, and were given luncheon meats with no added salt, if desired (optional); these were supplied regularly by the research staff. Subjects commencing the trial on the control diet were allowed to follow their usual diet but were asked to consume an in-house produced brown or white sliced pan bread equivalent in composition to the low-salt version but with its more typical salt content (1.2 g/100 g). Participants met the research staff weekly to receive breads and no-salt margarine/butter as well as luncheon meats (where applicable), and at these meetings the staff promoted compliance with the intervention and encouraged completion of the study protocol. BP and other assessments were made at baseline and at the end of week 5 and week 10.
Detailed Description
Brief background and context for the study: The World Health Organization's Global Action Plan for the Prevention and Control of Non-Communicable Disease includes a voluntary global target of a 30% relative reduction in mean population intake of salt/sodium by 2025. Bread and cured/processed meats collectively contribute anything from about a third upwards of total salt intake of adults in many Western countries. Reformulation of bread in terms of salt content remains an important measure to help achieve a reduction in salt intake in the population. Therefore, the aim of this study was to examine, using a 5-week cross-over design, food-based intervention trial, the potential for inclusion of 'low-salt' bread as part of a pragmatic reduced-salt diet on blood pressure (BP) in adults with slightly to moderately elevated BP. Design: The study consisted of a randomized crossover trial of the effect of reduced-salt intake or usual-salt intake for 5 weeks on BP (primary outcome) and biochemical markers of calcium and bone metabolism as well as plasma lipids (secondary outcomes) in adults with slightly to moderately elevated BP. Potential volunteers were screened for BP over 3 weeks preceding the intervention phase of the trial during which seated office systolic and diastolic BP were measured weekly and those with systolic BP >120 and <160 mmHg or a diastolic BP >80 and <95 mmHg were considered eligible. The dietary intervention phase of the trial was designed in two successive dietary periods, each of 5 weeks. Subjects were randomly assigned to the reduced-salt diet or their usual-salt diet (control) for 5 weeks, followed by crossover to the alternative dietary regimen for a further 5 weeks. At baseline (week 0), the subjects visited the Human Nutrition Studies Unit within University College Cork in a fasting state and had their BP measured. Prior to the baseline visit, subjects received instructions on how to collect a 24-h urine sample and were provided with a suitable container for collection. On the day of the baseline visit, subjects brought the 24-h urine sample collected from the previous day and deposited it in a cold room area dedicated for such collections. A blood sample was taken from each subject between 08.30 am and 10.30 am by a trained phlebotomist and anthropometric measures including height and weight, were taken. A health and lifestyle questionnaire, which assessed physical activity, general health, smoking status and alcohol consumption was completed by each subject. Subjects randomized to start on the reduced-salt diet were asked to restrict their consumption of dietary salt using a combination of pragmatic dietary advice as well as the replacement of bread and a limited number of other foods with equivalent foods which had lower salt content; these were provided to the participants. At the beginning of the salt restriction period, a research nutritionist provided the subjects with a list of the common salt-containing food and were asked to limit the consumption of such, as feasible. The subjects received in-house prepared 'low-salt (<0.3 g/100 g)' brown or white sliced pan bread as well as no-salt margarine/butter, and were given luncheon meats with no added salt, if desired (optional). Subjects commencing the trial on the control diet were allowed to follow their usual diet but were asked to consume an in-house produced brown or white sliced pan bread equivalent in composition to the low-salt version but with its more typical salt content (1.2 g/100 g). During the intervention phase, each participant made 2 further visits to the study unit, one each on the last day of dietary period 1 (week 5) and dietary period 2 (week 10). At these visits, BP measurements were taken as well as other anthropometric measures, including height and weight. An overnight fasting blood sample was also taken from each participant between 08.30 am and 10.30 am by a trained phlebotomist, and on each of the visits, the subjects provided a 24-hour urine sample collected the previous day. Following blood sampling the participants received their breakfast. Participants met the research staff weekly to receive breads and no-salt margarine/butter as well as luncheon meats (where applicable), and at these meetings the staff promoted compliance with the intervention and encouraged completion of the study protocol.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Elevated Blood Pressure
Keywords
Low-salt bread, Dietary sodium restriction, Pre-hypertension, Hypertension stage 1

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Outcomes Assessor
Masking Description
The biochemical outcome measures were assessed by researchers masked to the phase of the cross-over intervention from which the samples were derived.
Allocation
Randomized
Enrollment
97 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Usual-salt diet
Arm Type
Placebo Comparator
Arm Description
Usual-salt diet followed for 5 weeks
Arm Title
Reduced-salt diet
Arm Type
Active Comparator
Arm Description
Reduced-salt diet followed for 5 weeks
Intervention Type
Other
Intervention Name(s)
Usual-salt diet
Intervention Description
Subjects followed their usual-salt diet but were asked to consume an equivalent in-house produced brown or white sliced pan bread equivalent in composition to the low-salt version but with its more typical salt content (1.2 g/100 g).
Intervention Type
Other
Intervention Name(s)
Reduced-salt diet
Intervention Description
Subjects randomized to start on the reduced-salt diet were asked to restrict their consumption of dietary salt using a combination of pragmatic dietary advice as well as the replacement of bread and a limited number of other foods with equivalent foods which had lower salt content; these were provided to the participants. At the beginning of the salt restriction period, a research nutritionist provided the subjects with a list of the common salt-containing food (salted and naturally salty) and were asked to limit the consumption of such, as feasible. The subjects received in-house prepared 'low-salt (<0.3 g/100 g)' brown or white sliced pan bread as well as no-salt margarine/butter, and were given luncheon meats with no added salt if desired (optional).
Primary Outcome Measure Information:
Title
Systolic blood pressure at end of intervention periods
Description
Measured as seated office systolic blood pressure at end of usual salt dietary period and at end of reduced-salt dietary period
Time Frame
After 5 weeks of intervention
Secondary Outcome Measure Information:
Title
Diastolic blood pressure
Description
Measured as seated office diastolic blood pressure at end of usual salt dietary period and at end of reduced-salt dietary period
Time Frame
After 5 weeks of intervention
Title
Urinary Calcium
Description
Assessed in 24-hour urine collected at end of usual salt dietary period and at end of reduced-salt dietary period
Time Frame
After 5 weeks of intervention
Title
Urinary N-telopeptides of Type I collagen
Description
Biomarker of bone resorption; Assessed in 24-hour urine collected at end of usual salt dietary period and at end of reduced-salt dietary period
Time Frame
After 5 weeks of intervention
Title
Serum Parathyroid Hormone
Description
Index of calcium metabolism; Assessed in 24-hour urine collected at end of usual salt dietary period and at end of reduced-salt dietary period
Time Frame
After 5 weeks of intervention
Title
Serum C-telopeptide of Type I collagen
Description
Biomarker of bone resorption; Assessed in 24-hour urine collected at end of usual salt dietary period and at end of reduced-salt dietary period
Time Frame
After 5 weeks of intervention
Title
Serum Osteocalcin
Description
Biomarker of bone formation; Assessed in fasting serum collected at end of usual salt dietary period and at end of reduced-salt dietary period
Time Frame
After 5 weeks of intervention
Title
Serum Bone-specific alkaline phosphatase
Description
Biomarker of bone formation; Assessed in fasting serum collected at end of usual salt dietary period and at end of reduced-salt dietary period
Time Frame
After 5 weeks of intervention
Title
Plasma triglycerides
Description
Index of circulating lipids and CHD risk; Assessed in fasting plasma collected at end of usual salt dietary period and at end of reduced-salt dietary period
Time Frame
After 5 weeks of intervention
Title
Serum total-cholesterol
Description
Index of circulating lipids and CHD risk; Assessed in fasting plasma collected at end of usual salt dietary period and at end of reduced-salt dietary period
Time Frame
After 5 weeks of intervention
Title
Plasma LDL-cholesterol,
Description
Index of circulating lipids and CHD risk; Assessed in fasting plasma collected at end of usual salt dietary period and at end of reduced-salt dietary period
Time Frame
After 5 weeks of intervention
Title
Plasma HDL-cholesterol
Description
Index of circulating lipids and CHD risk; Assessed in fasting plasma collected at end of usual salt dietary period and at end of reduced-salt dietary period
Time Frame
After 5 weeks of intervention

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: consenting adult Caucasian men and women, aged ≤65 y; a seated office systolic BP >120 and <160 mmHg and/or a diastolic BP >80 and <95 mmHg (based on the mean BP across 3 screening visits as part of a pre-intervention phase of the trial) willing to consume study breads Exclusion Criteria: taking anti-hypertensive medication; taking any medications known to interfere with blood pressure or calcium or bone metabolism; Severe medical illness; celiac disease; hypercalcemia; known intestinal malabsorption syndrome, excessive alcohol use (>14 drinks/week); pregnancy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Kevin D Cashman, PhD
Organizational Affiliation
University College Cork
Official's Role
Principal Investigator
Facility Information:
Facility Name
School of Food and Nutritional Sciences, University College Cork
City
Cork
Country
Ireland

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

'Low-salt' Bread as a Means of Reducing Dietary Salt and Lowering Blood Pressure

We'll reach out to this number within 24 hrs